Behavioral, thermal and neurochemical effects of acute and chronic 3,4-methylenedioxymethamphetamine ("Ecstasy") self-administration

Behavioural Brain Research

Volumn 207, Issue 2, 2010, Pages 500-507

  Reveron, Maria Elena ^a   Maier, Esther Y ^a   Duvauchelle, Christine L ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Dopamine; Ecstasy; Hypothermia; In vivo microdialysis; MDMA stimulated locomotor activity; Nucleus accumbens; Serotonin

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; DOPAMINE; SEROTONIN; SODIUM CHLORIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR CHANGE; CONTROLLED STUDY; CORE TEMPERATURE; DRUG EFFECT; DRUG USE; EXTRACELLULAR SPACE; HYPOTHERMIA; IN VIVO STUDY; LOCOMOTION; MALE; MICRODIALYSIS; NEUROCHEMISTRY; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; SELF MEDICATION; SUBSTANCE ABUSE; TIME;

ANIMALS; BEHAVIOR, ANIMAL; BODY TEMPERATURE; CATHETERIZATION; CONDITIONING, OPERANT; DOPAMINE; DRUG TOLERANCE; EXTRACELLULAR SPACE; HALLUCINOGENS; MALE; MICRODIALYSIS; MOTOR ACTIVITY; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; SELF ADMINISTRATION; SEROTONIN; TIME FACTORS;

EID: 74449088708     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2009.10.038     Document Type: Article

References (82)

1. Aronson S.C., Black J.E., McDougle C.J., Scanley B.E., Jatlow P., Kosten T.R., et al. Serotonergic mechanisms of cocaine effects in humans. Psychopharmacology (Berl) 119 (1995) 179-185
2. Ball K.T., Budreau D., and Rebec G.V. Context-dependent behavioural and neuronal sensitization in striatum to MDMA (ecstasy) administration in rats. Eur J Neurosci 24 (2006) 217-228
3. Ball K.T., Wellman C.L., Fortenberry E., and Rebec G.V. Sensitizing regimens of MDMA (Ecstasy) elicit enduring and differential structural alterations in the brain motive circuit of the rat. Neuroscience 169 (2009) 264-274
4. Bassareo V., De Luca M.A., and Di Chiara G. Differential impact of pavlovian drug conditioned stimuli on in vivo dopamine transmission in the rat accumbens shell and core and in the prefrontal cortex. Psychopharmacology (Berl) 191 (2007) 689-703
5. Battaglia G., Yeh S.Y., and De Souza E.B. MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons. Pharmacol Biochem Behav 29 (1988) 269-274
6. Baumann M.H., Clark R.D., Franken F.H., Rutter J.J., and Rothman R.B. Tolerance to 3,4-methylenedioxymethamphetamine in rats exposed to single high-dose binges. Neuroscience 152 (2008) 773-784
7. Baumann M.H., Clark R.D., and Rothman R.B. Locomotor stimulation produced by 3,4-methylenedioxymethamphetamine (MDMA) is correlated with dialysate levels of serotonin and dopamine in rat brain. Pharmacol Biochem Behav 90 (2008) 208-217
8. Baumann M.H., Wang X., and Rothman R.B. 3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings. Psychopharmacology (Berl) 189 (2007) 407-424
9. Braida D., Iosue S., Pegorini S., and Sala M. 3,4-Methylenedioxymethamphetamine-induced conditioned place preference (CPP) is mediated by endocannabinoid system. Pharmacol Res 51 (2005) 177-182
10. Broening H.W., Bowyer J.F., and Slikker Jr. W. Age-dependent sensitivity of rats to the long-term effects of the serotonergic neurotoxicant (±)-3,4-methylenedioxymethamphetamine (MDMA) correlates with the magnitude of the MDMA-induced thermal response. J Pharmacol Exp Ther 275 (1995) 325-333
11. Bubar M.J., Pack K.M., Frankel P.S., and Cunningham K.A. Effects of dopamine D1- or D2-like receptor antagonists on the hypermotive and discriminative stimulus effects of (+)-MDMA. Psychopharmacology (Berl) 173 (2004) 326-336
12. Cadoni C., Solinas M., Pisanu A., Zernig G., Acquas E., and Di Chiara G. Effect of 3,4-methylendioxymethamphetamine (MDMA, "ecstasy") on dopamine transmission in the nucleus accumbens shell and core. Brain Res 1055 (2005) 143-148
13. Callaway C.W., Rempel N., Peng R.Y., and Geyer M.A. Serotonin 5-HT1-like receptors mediate hyperactivity in rats induced by 3,4-methylenedioxymethamphetamine. Neuropsychopharmacology 7 (1992) 113-127
14. Callaway C.W., Wing L.L., and Geyer M.A. Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats. J Pharmacol Exp Ther 254 (1990) 456-464
15. Carroll M.E., Lac S.T., Asencio M., and Kragh R. Fluoxetine reduces intravenous cocaine self-administration in rats. Pharmacol Biochem Behav 35 (1990) 237-244
16. Clemens K.J., Cornish J.L., Hunt G.E., and McGregor I.S. Repeated weekly exposure to MDMA, methamphetamine or their combination: long-term behavioural and neurochemical effects in rats. Drug Alcohol Depend 86 (2007) 183-190
17. Colussi-Mas J., and Schenk S. Acute and sensitized response to 3,4-methylenedioxymethamphetamine in rats: different behavioral profiles reflected in different patterns of Fos expression. Eur J Neurosci 28 (2008) 1895-1910
18. Curran H.V., Rees H., Hoare T., Hoshi R., and Bond A. Empathy and aggression: two faces of ecstasy? A study of interpretative cognitive bias and mood change in ecstasy users. Psychopharmacology (Berl) 173 (2004) 425-433
19. D'Souza M.S., and Duvauchelle C.L. Certain or uncertain cocaine expectations influence accumbens dopamine responses to self-administered cocaine and non-rewarded operant behavior. Eur Neuropsychopharmacol 18 (2008) 628-638
20. Dafters R.I. Effect of ambient temperature on hyperthermia and hyperkinesis induced by 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") in rats. Psychopharmacology (Berl) 114 (1994) 505-508
21. Dafters R.I., and Lynch E. Persistent loss of thermoregulation in the rat induced by 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy") but not by fenfluramine. Psychopharmacology (Berl) 138 (1998) 207-212
22. Daniela E., Brennan K., Gittings D., Hely L., and Schenk S. Effect of SCH 23390 on (±)-3,4-methylenedioxymethamphetamine hyperactivity and self-administration in rats. Pharmacol Biochem Behav 77 (2004) 745-750
23. De La Garza II R., Fabrizio K.R., and Gupta A. Relevance of rodent models of intravenous MDMA self-administration to human MDMA consumption patterns. Psychopharmacology (Berl) 189 (2007) 425-434
24. Di Chiara G. A motivational learning hypothesis of the role of mesolimbic dopamine in compulsive drug use. J Psychopharmacol 12 (1998) 54-67
25. Emmett-Oglesby M.W., Peltier R.L., Depoortere R.Y., Pickering C.L., Hooper M.L., Gong Y.H., et al. Tolerance to self-administration of cocaine in rats: time course and dose-response determination using a multi-dose method. Drug Alcohol Depend 32 (1993) 247-256
26. Feduccia A.A., and Duvauchelle C.L. Auditory stimuli enhance MDMA-conditioned reward and MDMA-induced nucleus accumbens dopamine, serotonin and locomotor responses. Brain Res Bull 77 (2008) 189-196
27. Ferrario C.R., Gorny G., Crombag H.S., Li Y., Kolb B., and Robinson T.E. Neural and behavioral plasticity associated with the transition from controlled to escalated cocaine use. Biol Psychiatry 58 (2005) 751-759
28. Flagel S.B., and Robinson T.E. Quantifying the psychomotor activating effects of cocaine in the rat. Behav Pharmacol 18 (2007) 297-302
29. Fletcher P.J., Korth K.M., Robinson S.R., and Baker G.B. Multiple 5-HT receptors are involved in the effects of acute MDMA treatment: studies on locomotor activity and responding for conditioned reinforcement. Psychopharmacology (Berl) 162 (2002) 282-291
30. Freedman R.R., Johanson C.E., and Tancer M.E. Thermoregulatory effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans. Psychopharmacology (Berl) 183 (2005) 248-256
31. Gough B., Ali S.F., Slikker Jr. W., and Holson R.R. Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on monoamines in rat caudate. Pharmacol Biochem Behav 39 (1991) 619-623
32. Green A.R., O'Shea E., and Colado M.I. A review of the mechanisms involved in the acute MDMA (ecstasy)-induced hyperthermic response. Eur J Pharmacol 500 (2004) 3-13
33. Green A.R., Sanchez V., O'Shea E., Saadat K.S., Elliott J.M., and Colado M.I. Effect of ambient temperature and a prior neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA) on the hyperthermic response of rats to a single or repeated ('binge' ingestion) low dose of MDMA. Psychopharmacology (Berl) 173 (2004) 264-269
34. Herin D.V., Liu S., Ullrich T., Rice K.C., and Cunningham K.A. Role of the serotonin 5-HT2A receptor in the hyperlocomotive and hyperthermic effects of (+)-3,4-methylenedioxymethamphetamine. Psychopharmacology (Berl) 178 (2005) 505-513
35. Howell L.L., and Byrd L.D. Serotonergic modulation of the behavioral effects of cocaine in the squirrel monkey. J Pharmacol Exp Ther 275 (1995) 1551-1559
36. Hubner C.B., Bird M., Rassnick S., and Kornetsky C. The threshold lowering effects of MDMA (ecstasy) on brain-stimulation reward. Psychopharmacology (Berl) 95 (1988) 49-51
37. Ikegami A., and Duvauchelle C.L. Nucleus accumbens and medial prefrontal cortex dopaminergic response to self-administered cocaine in naive rats. Neurosci Lett 354 (2004) 205-208
38. Ikegami A., Olsen C.M., D'Souza M.S., and Duvauchelle C.L. Experience-dependent effects of cocaine self-administration/conditioning on prefrontal and accumbens dopamine responses. Behav Neurosci 121 (2007) 389-400
39. Jaehne E.J., Salem A., and Irvine R.J. The effect of long-term repeated exposure to 3,4-methylenedioxymethamphetamine on cardiovascular and thermoregulatory changes. Psychopharmacology (Berl) 201 (2008) 161-170
40. Johnson M.P., Hoffman A.J., and Nichols D.E. Effects of the enantiomers of MDA, MDMA and related analogues on [3H]serotonin and [3H]dopamine release from superfused rat brain slices. Eur J Pharmacol 132 (1986) 269-276
41. Kankaanpaa A., Meririnne E., Lillsunde P., and Seppala T. The acute effects of amphetamine derivatives on extracellular serotonin and dopamine levels in rat nucleus accumbens. Pharmacol Biochem Behav 59 (1998) 1003-1009
42. Kelly P.H., and Iversen S.D. Selective 6OHDA-induced destruction of mesolimbic dopamine neurons: abolition of psychostimulant-induced locomotor activity in rats. Eur J Pharmacol 40 (1976) 45-56
43. Koch S., and Galloway M.P. MDMA induced dopamine release in vivo: role of endogenous serotonin. J Neural Transm 104 (1997) 135-146
44. Kurling S., Kankaanpaa A., and Seppala T. Sub-chronic nandrolone treatment modifies neurochemical and behavioral effects of amphetamine and 3,4-methylenedioxymethamphetamine (MDMA) in rats. Behav Brain Res 189 (2008) 191-201
45. Ladurelle N., Roques B.P., and Dauge V. The transfer of rats from a familiar to a novel environment prolongs the increase of extracellular dopamine efflux induced by CCK8 in the posterior nucleus accumbens. J Neurosci 15 (1995) 3118-3127
46. Leyton M. Conditioned and sensitized responses to stimulant drugs in humans. Prog Neuropsychopharmacol Biol Psychiatry 31 (2007) 1601-1613
47. Lile J.A., Ross J.T., and Nader M.A. A comparison of the reinforcing efficacy of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") with cocaine in rhesus monkeys. Drug Alcohol Depend 78 (2005) 135-140
48. Lin H.Q., Jackson D.M., Atrens D.M., Christie M.J., and McGregor I.S. Serotonergic modulation of 3,4-methylenedioxymethamphetamine (MDMA)-elicited reduction of response rate but not rewarding threshold in accumbal self-stimulation. Brain Res 744 (1997) 351-357
49. Malberg J.E., and Seiden L.S. Small changes in ambient temperature cause large changes in 3,4-methylenedioxymethamphetamine (MDMA)-induced serotonin neurotoxicity and core body temperature in the rat. J Neurosci 181 (1998) 5086-5094
50. Mendelson J.H., Sholar M., Mello N.K., Teoh S.K., and Sholar J.W. Cocaine tolerance: behavioral, cardiovascular, and neuroendocrine function in men. Neuropsychopharmacology 18 (1998) 263-271
51. Munzar P., Baumann M.H., Shoaib M., and Goldberg S.R. Effects of dopamine and serotonin-releasing agents on methamphetamine discrimination and self-administration in rats. Psychopharmacology (Berl) 141 (1999) 287-296
52. Nash Jr. J.F., Meltzer H.Y., and Gudelsky G.A. Elevation of serum prolactin and corticosterone concentrations in the rat after the administration of 3,4-methylenedioxymethamphetamine. J Pharmacol Exp Ther 245 (1988) 873-879
53. O'Shea E., Escobedo I., Orio L., Sanchez V., Navarro M., Green A.R., et al. Elevation of ambient room temperature has differential effects on MDMA-induced 5-HT and dopamine release in striatum and nucleus accumbens of rats. Neuropsychopharmacology 30 (2005) 1312-1323
54. Olds M.E., and Christenson T. Effects of drive and training on extinction after self-stimulation and food reward. Am J Physiol 219 (1970) 208-213
55. Olsen C.M., and Duvauchelle C.L. Intra-prefrontal cortex injections of SCH 23390 influence nucleus accumbens dopamine levels 24 h post-infusion. Brain Res 922 (2001) 80-86
56. Parrott A.C. Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy. J Psychopharmacol 19 (2005) 71-83
57. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (Atlas & Computer Graphics Files) (1997), Academic Press, Inc., San Diego
58. Pierce R.C., and Kalivas P.W. Locomotor behavior. Curr Protoc Neurosci 40 (2007) 1-8
59. Piper B.J., Fraiman J.B., and Meyer J.S. Repeated MDMA ("Ecstasy") exposure in adolescent male rats alters temperature regulation, spontaneous motor activity, attention, and serotonin transporter binding. Dev Psychobiol 47 (2005) 145-157
60. Piper B.J., and Meyer J.S. Increased responsiveness to MDMA in adult rats treated neonatally with MDMA. Neurotoxicol Teratol 28 (2006) 95-102
61. Quednow B.B., Jessen F., Kuhn K.U., Maier W., Daum I., and Wagner M. Memory deficits in abstinent MDMA (ecstasy) users: neuropsychological evidence of frontal dysfunction. J Psychopharmacol 20 (2006) 373-384
62. Ratzenboeck E., Saria A., Kriechbaum N., and Zernig G. Reinforcing effects of MDMA ("ecstasy") in drug-naive and cocaine-trained rats. Pharmacology 62 (2001) 138-144
63. Reveron M.E., Maier E.Y., and Duvauchelle C.L. Experience-dependent changes in temperature and behavioral activity induced by MDMA. Physiol Behav 89 (2006) 358-363
64. Rogers G., Elston J., Garside R., Roome C., Taylor R., Younger P., et al. The harmful health effects of recreational ecstasy: a systematic review of observational evidence. Health Technol Assess 13 (2009) 1-315
65. Rothman R.B., and Baumann M.H. Balance between dopamine and serotonin release modulates behavioral effects of amphetamine-type drugs. Ann N Y Acad Sci 1074 (2006) 245-260
66. Satel S.L., Krystal J.H., Delgado P.L., Kosten T.R., and Charney D.S. Tryptophan depletion and attenuation of cue-induced craving for cocaine. Am J Psychiatry 152 (1995) 778-783
67. Schenk S., Gittings D., Johnstone M., and Daniela E. Development, maintenance and temporal pattern of self-administration maintained by ecstasy (MDMA) in rats. Psychopharmacology (Berl) 169 (2003) 21-27
68. Schlaepfer T.E., Pearlson G.D., Wong D.F., Marenco S., and Dannals R.F. PET study of competition between intravenous cocaine and [11C]raclopride at dopamine receptors in human subjects. Am J Psychiatry 154 (1997) 1209-1213
69. Schmidt C.J., Levin J.A., and Lovenberg W. In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain. Biochem Pharmacol 36 (1987) 747-755
70. Schmidt C.J., Wu L., and Lovenberg W. Methylenedioxymethamphetamine: a potentially neurotoxic amphetamine analogue. Eur J Pharmacol 124 (1986) 175-178
71. Sprague J.E., Moze P., Caden D., Rusyniak D.E., Holmes C., Goldstein D.S., et al. Carvedilol reverses hyperthermia and attenuates rhabdomyolysis induced by 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) in an animal model. Crit Care Med 33 (2005) 1311-1316
72. Stone D.M., Johnson M., Hanson G.R., and Gibb J.W. A comparison of the neurotoxic potential of methylenedioxyamphetamine (MDA) and its N-methylated and N-ethylated derivatives. Eur J Pharm 134 (1987) 245-248
73. Tanda G., Pontieri F.E., Frau R., and Di Chiara G. Contribution of blockade of the noradrenaline carrier to the increase of extracellular dopamine in the rat prefrontal cortex by amphetamine and cocaine. Eur J Neurosci 9 (1997) 2077-2085
74. Tang A., Bungay P.M., and Gonzales R.A. Characterization of probe and tissue factors that influence interpretation of quantitative microdialysis experiments for dopamine. J Neurosci Methods 126 (2003) 1-11
75. Trigo J.M., Renoir T., Lanfumey L., Hamon M., Lesch K.P., Robledo P., et al. 3,4-Methylenedioxymethamphetamine self-administration is abolished in serotonin transporter knockout mice. Biol Psychiatry 62 (2007) 669-679
76. Verrico C.D., Miller G.M., and Madras B.K. MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment. Psychopharmacology (Berl) 189 (2007) 489-503
77. Volkow N.D., Fowler J.S., and Wang G.J. The addicted human brain viewed in the light of imaging studies: brain circuits and treatment strategies. Neuropharmacology 47 Suppl. 1 (2004) 3-13
78. Volkow N.D., Fowler J.S., Wang G.J., Ding Y.S., and Gatley S.J. Role of dopamine in the therapeutic and reinforcing effects of methylphenidate in humans: results from imaging studies. Eur Neuropsychopharmacol 12 (2002) 557-566
79. Volkow N.D., Fowler J.S., Wang G.J., and Goldstein R.Z. Role of dopamine, the frontal cortex and memory circuits in drug addiction: insight from imaging studies. Neurobiol Learn Mem 78 (2002) 610-624
80. Wang Z., and Woolverton W.L. Estimating the relative reinforcing strength of (±)-3,4-methylenedioxymethamphetamine (MDMA) and its isomers in rhesus monkeys: comparison to (+)-methamphetamine. Psychopharmacology (Berl) 189 (2007) 483-488
81. Zakzanis K.K., and Campbell Z. Memory impairment in now abstinent MDMA users and continued users: a longitudinal follow-up. Neurology 66 (2006) 740-741
82. Zernig G., Ahmed S.H., Cardinal R.N., Morgan D., Acquas E., Foltin R.W., et al. Explaining the escalation of drug use in substance dependence: models and appropriate animal laboratory tests. Pharmacology 80 (2007) 65-119